Quest Diagnostics Inc
NYSE:DGX
Relative Value
The Relative Value of one DGX stock under the Base Case scenario is 165.74 USD. Compared to the current market price of 141.83 USD, Quest Diagnostics Inc is Undervalued by 14%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
DGX Competitors Multiples
Quest Diagnostics Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.7B USD | 1.7 | 18.7 | 11 | 14.9 | ||
US |
Cigna Corp
NYSE:CI
|
104.7B USD | 0.5 | 20.3 | 10.4 | 13.9 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
96.6B EUR | 0.5 | 20 | 10.3 | 13.7 | |
US |
CVS Health Corp
NYSE:CVS
|
87.1B USD | 0.2 | 10.4 | 8.9 | 8.9 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
22B EUR | 1.1 | 44.1 | 10.3 | 24.5 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17.5B USD | 1.4 | 40.3 | 12.2 | 18.4 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.6B EUR | 0.7 | -26.3 | 10 | 22.5 | |
US |
DaVita Inc
NYSE:DVA
|
12.2B USD | 1 | 17.6 | 8.5 | 12.5 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.4B EUR | 0.6 | 22.8 | 6.8 | 16.2 | |
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 | ||
US |
Chemed Corp
NYSE:CHE
|
8.5B USD | 3.7 | 29.9 | 18.8 | 21.9 |